Optimized in vivo performance of acid-liable micelles for the treatment of rheumatoid arthritis by one single injection
- 30 Downloads
Current therapeutic limitations existed in effective treatment of rheumatoid arthritis (RA) have motivated numerous researches on finding new strategies. Regarding to the non-targeted distribution and uncontrollable in vivo performance which hinder the effective treatment for RA, we designed an acid-responsive polymeric micelle formulation by attaching the dexamethasone (Dex) to the side chains of a wheat-like polyethylene glycol (PEG) derivate via a hydrazone linker. The self-assembly micelles with the diameter around 50 nm could passively migrate to inflamed sites. The presence of hydrazone linkers avoided the drug leakage in circulation and ensured the preferential release in acidic arthritic joints. Here, we evaluated how the polymer-drug micelles with different density of drug payloads influenced the release pattern, pharmacokinetics and biodistribution, as well as the most importantly, the duration of the therapeutic efficacy. Our exploration would offer the chemical and structural basis for designing and optimizing the nanocarriers for enhanced therapeutic efficacy.
Keywordsrheumatoid arthritis pH-responsive micelles dexamethasone
Unable to display preview. Download preview PDF.
We acknowledge financial support from the National Natural Science Foundation of China (No. 81673362).
12274_2018_2233_MOESM1_ESM.pdf (1.6 mb)
- Quan, L. D.; Zhang, Y. J.; Crielaard, B. J.; Dusad, A.; Lele, S. M.; Rijcken, C. J. F.; Metselaar, J. M.; Kostková, H.; Etrych, T.; Ulbrich, K. et al. Nanomedicines for inflammatory arthritis: Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano 2013, 8, 458–466.CrossRefGoogle Scholar
- Crielaard, B. J.; Rijcken, C. J. F.; Quan, L. D.; van der Wal, S.; Altintas, I.; van der Pot, M.; Kruijtzer, J. A. W.; Liskamp, R. M. J.; Schiffelers, R. M.; van Nostrum, C. F. et al. Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew. Chem., Int. Ed. 2012, 51, 7254–7258.CrossRefGoogle Scholar
- Metselaar, J. M.; van den Berg, W. B.; Holthuysen, A. E. M.; Wauben, M. H. M.; Storm, G.; van Lent, P. L. E. M. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheum. Dis. 2004, 63, 348–353.CrossRefGoogle Scholar
© Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018